MAPT and Alzheimer disease: Moreover, the recent Glycogen Synthase Kinase 3 (GSK-3) hypothesis of AD suggests that GSK3, involved in the regulation of glial cells functioning, could exert a role in amyloid deposition and tau (a microtubule-associated protein) hyper-phosphorylation [6-8].